Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
Natural polyphenol-taurine-based nanoparticles for oral ulcer therapy
Xun Pan1,2, Hengjie Zhang3, Jinling Zhao3
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China. ferowang@hotmail.com.
None:
Oral ulcers are the most common disease of the oral mucosa, and the pathogenesis is caused by a local overload of reactive oxygen species (ROS) that precipitates tissue breakdown, which, in turn, leads to the formation of ulcers. Here, we report a one-step oxidative copolymerization strategy to synthesize pH/ROS dual-responsive protocatechualdehyde taurine nanoparticles (PAT NPs) by cross-linking protocatechualdehyde and taurine (Tau). These PAT NPs combine excellent biocompatibility and multiple functions, such as efficient scavenging of free radicals, neutralization of lipopolysaccharide, protection of mitochondria, inhibition of M1 macrophage polarization, promotion of M2 polarization, promotion of anti-inflammatory activity and promotion of cell migration and angiogenesis. The animal ulcer model demonstrated that the PAT NPs can simultaneously inhibit inflammation, promote vascularization, and significantly shorten ulcer healing time, providing a new paradigm for the translation of natural polyphenol-taurine nanomaterials in the field of oral mucosal repair.
More Related Videos
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Bioavailability Enhancement: Drug Permeability Enhancement

